Development of PSMA-targeting agent using astatin-211

Tomoki Yamashita

Presentation information

[WFNMB]Poster

The13th Congress of the World Federation of Nuclear Medicine and Biology(WFNMB2022) » [WFNMB]Poster Program

Nuclear Medicine Innovation1

Therapy

Sun. Sep 11, 2022 8:00 AM - 8:00 PM Web distribution only (配信のみ)

[WP-28-1] Development of PSMA-targeting agent using astatin-211

Tomoki Yamashita¹、Yuta Kaizuka¹、Mizuki Hirayama¹、Takahiro Yasuda¹、Kazuhiro Takahashi²、Hiroyuki Suzuki¹、Tomoya Uehara¹ (1.Graduate Shool Of Pharmaceutical Sciences, Chiba University、2.Fukushima Medical University)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

« Previous in this session
Next in this session »

▲

Presentation information

Nuclear Medicine Innovation1

Therapy

[WP-28-1] Development of PSMA-targeting agent using astatin-211

Password